Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: two year results from a comparative effectiveness randomized clinical trial ( Ophthalmology . 2016;123:1351-1359)
2020 ◽
Vol 40
(5)
◽
pp. 1147-1154
◽
Keyword(s):
2005 ◽
Vol 46
(10)
◽
pp. 3845
◽
2016 ◽
Vol 47
(6)
◽
pp. 536-543
Keyword(s):
2018 ◽
Vol 59
(3)
◽
pp. 1199
◽